News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No articles were published in the past hour.
  • No market-moving headlines emerged during the hour.
  • No new economic data releases occurred in the past hour.
  • No notable political developments were reported in the last hour.
  • No major global events were reported over the past hour.

Latest Articles

OKYO Pharma Announces Purchase of Shares by Chief Medical Officer

OKYO Pharma Announces Purchase of Shares by Chief Medical Officer

OKYO Pharma's Chief Medical Officer, Dr. Flavio Mantelli, has purchased 20,000 shares of the company at $1.40 per share. This insider buying occurs as the company prepares to initiate a global Phase 3 clinical trial for urcosimod, targeting neuropathic corneal pain. The move signals confidence in the upcoming pivotal study and the company’s therape…

AmpliTech Group Receives FCC and ISED Certifications For Its Newly Released And Innovative AI-Ready 4T8R Open RAN Radio, Expanding Commercial Opportunities Across North America

AmpliTech Group Receives FCC and ISED Certifications For Its Newly Released And Innovative AI-Ready 4T8R Open RAN Radio, Expanding Commercial Opportunities Across North America

AmpliTech Group announced that its new Outdoor Macro Cell 4T8R Open RAN Radio Unit has received FCC approval in the U.S. and ISED certification in Canada, enabling deployment across North America. The AI-ready 4T8R architecture offers improved network performance and cost efficiency, positioning AmpliTech to capitalize on expanding 5G, Open RAN mod…

Radiopharm Theranostics Announces Positive Phase 2b Trial Results of RAD 101 for Diagnosis of Brain Metastases

Radiopharm Theranostics Announces Positive Phase 2b Trial Results of RAD 101 for Diagnosis of Brain Metastases

Radiopharm Theranostics announced positive Phase 2b trial results for RAD101, a novel PET imaging agent targeting fatty acid synthase, demonstrating 93% concordance with MRI and 86% sensitivity in detecting recurrent brain metastases. The company plans to initiate a US Phase 3 pivotal trial in Q4 2026, addressing a significant unmet need in neuro-o…

Old National Bancorp Reports Record Second Quarter 2026 Results; Announces Enhanced Executive Leadership Structure

Old National Bancorp Reports Record Second Quarter 2026 Results; Announces Enhanced Executive Leadership Structure

Old National Bancorp, a top 25 U.S. bank, reported record second quarter 2026 net income applicable to common shares of $249.4 million with diluted EPS of $0.65, driven by strong loan growth, stable net interest margin, disciplined expense management, and robust credit quality. The company also announced an enhanced executive leadership structure t…

Publication in Clinical Reviews in Allergy & Immunology Summarizes Decades of Evidence Supporting Bradykinin B2 Receptor as a Validated Therapeutic Target in Bradykinin-Mediated Angioedema

Publication in Clinical Reviews in Allergy & Immunology Summarizes Decades of Evidence Supporting Bradykinin B2 Receptor as a Validated Therapeutic Target in Bradykinin-Mediated Angioedema

Pharvaris, a Nasdaq-listed late-stage biopharmaceutical company, announced a publication in Clinical Reviews in Allergy & Immunology providing an in-depth review of the bradykinin B2 receptor's role in bradykinin-mediated angioedema and other immunological diseases. The article consolidates decades of research supporting the bradykinin B2 receptor …

Regulatory Breakthrough and Booking Momentum Make WRAP a Tactical Buy

Regulatory Breakthrough and Booking Momentum Make WRAP a Tactical Buy

Wrap Technologies just cleared a large regulatory hurdle with an ATF ruling classifying the BolaWrap 150 as an instrument of restraint, not a firearm. That clarity shortens procurement cycles and opens federal, corrections, healthcare and international channels. With Q1 revenue up 45% YoY, $3.2M in bookings, and improved cash burn, the upgrade to a…

World Bank Warns Middle East Escalation Could Cut Global Growth to 1.3% in 2026

World Bank Warns Middle East Escalation Could Cut Global Growth to 1.3% in 2026

The World Bank's chief economist cautioned that an intensification of conflict between the United States and Iran could propel global headline inflation toward 4.5%, drive policy rates higher and depress worldwide growth to as little as 1.3% in 2026. In a late-July interview, he said the bank's downside scenario - with fighting lasting six months o…

U.S. Court Sets June 2027 Trial for Ousted Venezuelan Leader on Drug Charges

U.S. Court Sets June 2027 Trial for Ousted Venezuelan Leader on Drug Charges

A Manhattan federal judge has scheduled a June 1, 2027 trial date for ousted Venezuelan President Nicolas Maduro and his wife Cilia Flores on U.S. drug trafficking charges. The court also established deadlines for defense motions, including an immunity challenge, and for production of evidence that may include classified material. Maduro and Flores…

Rubio Orders Diplomats to Downplay Talk of a U.S. Tech 'Kill Switch'

Rubio Orders Diplomats to Downplay Talk of a U.S. Tech 'Kill Switch'

A State Department cable dated July 16 directed U.S. diplomats to rebut international claims that Washington wields a 'kill switch' over American technology, following a brief decision that blocked foreigners from accessing leading AI models. The guidance frames short pauses and voluntary testing windows as safety measures rather than tools of coer…

Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media

Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media

Repligen Corporation is acquiring BioLife Solutions for approximately $1.5 billion to strengthen its position in the rapidly growing cell therapy market. The transaction, consisting of 64% stock and 36% cash, will add BioLife's differentiated biopreservation media products and expand Repligen's offerings with high-margin recurring revenue assets. T…

Lulus to Report Second Quarter 2026 Results on August 12, 2026

Lulus to Report Second Quarter 2026 Results on August 12, 2026

Lulu's Fashion Lounge Holdings, Inc. will report its second quarter 2026 financial results on August 12, 2026, after market close. The company will host a live webcast and conference call with the investment community, accessible via its investor relations website and phone lines. A replay of the call will be available for seven days.

Cal-Maine Foods Reports Fourth Quarter and Fiscal 2026 Results

Cal-Maine Foods Reports Fourth Quarter and Fiscal 2026 Results

Cal-Maine Foods, the largest US egg producer, announced fiscal 2026 results showing a nearly 50% decline in Q4 net sales and a 31.7% fall for the full fiscal year compared to fiscal 2025. The company reported a net loss of $35.9 million in Q4, marking a significant downturn driven by historically low wholesale egg prices due to industry oversupply.…

FirstCash Announces Planned Leadership Succession

FirstCash Announces Planned Leadership Succession

FirstCash Holdings, Inc., a leading international pawn store operator, announced a long-term leadership succession plan. CEO Rick L. Wessel will transition to Executive Chairman, with President and COO T. Brent Stuart becoming CEO and President starting January 1, 2027. These planned changes aim to ensure smooth leadership continuity while maintain…